z-logo
Premium
O1–06–08: Activation of microglia by nasal vaccination with a proteosome based adjuvant and glatiramer acetate clears a–beta in an antibody independent fashion in a mouse model of Alzheimer's disease
Author(s) -
Weiner Howard L.,
Petrovic Sanja,
Xia Weiming,
Goldberg Matthew,
Vega Jose,
Burt David S.,
Frenkel Dan
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.068
Subject(s) - glatiramer acetate , medicine , adjuvant , microglia , vaccination , antibody , nasal administration , immunology , immunization , neurotoxicity , multiple sclerosis , toxicity , inflammation

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom